pindolol has been researched along with Cardiovascular Diseases in 7 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These differences account for many of the observed variations in drug action and dosage scheduling as well as for some of the side effects." | 1.27 | Beta-adrenergic blockers. Choosing among them. ( McGoon, MD; Vlietstra, RE, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Del Giaccio, A | 1 |
| Eblen-Zajjur, A | 1 |
| Vlietstra, RE | 1 |
| McGoon, MD | 1 |
| Nagatomo, T | 1 |
| Hosohata, Y | 1 |
| Ohnuki, T | 1 |
| Nakamura, T | 1 |
| Hattori, K | 1 |
| Suzuki, J | 1 |
| Ishiguro, M | 1 |
| Rodor, F | 1 |
| Poyen, B | 1 |
| Santoni, Y | 1 |
| Thomas, JL | 1 |
| Ripert, JL | 1 |
| Jouglard, J | 1 |
| Furberg, CD | 1 |
| Schäcke, G | 1 |
| Bloedner, CD | 1 |
| Valentin, H | 1 |
| Ellner, O | 1 |
| Kaffarnik, H | 1 |
| Warning, A | 1 |
2 reviews available for pindolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Bopindolol: pharmacological basis and clinical implications.
Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Diseases; Disease Models, Animal; Hemodynamics; | 2001 |
Beta-adrenergic receptor blocking drugs in hypertrophic cardiomyopathy, autonomically mediated cardiovascular functional disorders and Fallot's tetralogy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Drug | 1974 |
1 trial available for pindolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular drugs in human mechanical nociception: digoxin, amlodipine, propranolol, pindolol and atenolol.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Atenolol; Cardiovascular Diseases; Cross-Sectional Studi | 2010 |
4 other studies available for pindolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Beta-adrenergic blockers. Choosing among them.
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiovascular Diseases; Humans; Kinetics; Metoprolol; Nadolo | 1984 |
[Hallucinations after taking pindolol (author's transl)].
Topics: Adult; Cardiovascular Diseases; Female; Hallucinations; Humans; Male; Middle Aged; Pindolol | 1979 |
[Preventive, long-term studies of ECG and heart rate using radiotelemetry during beta sympatholysis].
Topics: Adrenergic beta-Antagonists; Age Factors; Blood Pressure; Cardiovascular Diseases; Coronary Disease; | 1972 |
[Beta sympatholytic therapy in functional cardiovascular syndromes. Studies using Visken].
Topics: Adolescent; Adult; Autonomic Nervous System; Blood Pressure; Cardiovascular Diseases; Female; Heart | 1973 |